Acute myopathic syndrome induced by clofibrate in periodic dialysis
Gutíerrez Millet, V.; Gómez Tejada, E.; Bello Nicolau, I.; Barrientos Guzman, A.; Ruilope Urioste, L.M.; Rodicio Diaz, J.L.
Revista Clinica Espanola 141(1): 85-89
1976
ISSN/ISBN: 0014-2565 PMID: 948661 Document Number: 107216
Document emailed within 1 workday
Related Documents
Carrella, M.; Del Vecchio-Blanco, C.; De Santo, N.G.; Esposito, R. 1973: Detection of Australia antigen in 53 patients during periodic dialysis treatment and in staff members of a dialysis unit Minerva Medica 64(19): 976-980Dinc, A.; Erdem, H.; Rowczenio, D.; Simsek, I.; Pay, S.; Bahce, M.; Lachmann, H. 2005: Autosomal dominant periodic fever with AA amyloidosis: tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in a Turkish family Journal of Nephrology 18(5): 626-629
Mertz, D.P. 1980: Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate Fortschritte der Medizin 98(45): 1761-1766
Bojs, G.; Fahlén, M.; Lapidus, L. 1979: Clofibrate-induced muscle problems Lakartidningen 76(30-31): 2631-2632
Kra, S.J. 1974: Muscle syndrome with clofibrate usage Connecticut Medicine 38(7): 348-349
Uszycka-Karcz, M.; Marczak, E.; Kuiszczyk, A.; Karcz, J.; Gross, R. 1978: Peritoneal dialysis in the treatment of acute renal failure with hemolytic-uremic syndrome Pediatria Polska 53(1): 35-40
Tsukada, H.; Mochizuki, Y.; Gotoh, M. 1975: Matrical inclusions induced by clofibrate in hepatic microbodies of rats fed 2-acetylaminofluorene Journal of the National Cancer Institute 54(2): 519-523
Goicoechea, M.A. 2004: Antihypertensive therapy in patients with 4 and 5 stage chronic kidney disease undergoing periodic dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24 Suppl (6): 161-171; 187-235
Cruces R, P.; Roque E, J.; Ronco M, R.; Valenzuela S, A.; Torres N, R.; Ossandón C, F. 2006: Massive acute hydrothorax secondary to peritoneal dialysis in a hemolytic uremic syndrome. Report of a case Revista Medica de Chile 134(1): 91-94
Lambrecht, E.R.; Meems, B.J. 1987: A case of neuroleptic malignant syndrome with myoglobinuric acute renal failure treated with dialysis and levodopa Netherlands Journal of Medicine 30(1-2): 80-84
Fabre, J.; Denizot, M.; Wildi, E.; Micheli, H.; Berthoud, S. 1973: Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome Schweizerische Rundschau für Medizin Praxis 62(23): 732-737
Pickart, L. 1981: Suppression of acute-phase synthesis of fibrinogen by a hypolipidemic drug (clofibrate) International Journal of Tissue Reactions 3(2): 65-72
Hampl, H.; Klopp, H.W.; Michels, N.; Mahiout, A.; Schilling, H.; Wolfgruber, M.; Schiller, R.; Hanefeld, F.; Kessel, M. 1983: Electro-encephalographic study of the disequilibrium syndrome during bicarbonate dialysis and acetate dialysis Nephrologie 4(4-5): 220-224
Appels, C.W.Y.; Kloppenburg, M. 2006: Muckle-Wells syndrome: a rare periodic fever syndrome Nederlands Tijdschrift Voor Geneeskunde 150(29): 1628-1631
Stevens, T.J.; Stafford, W.W.; Day, C.E.; Block, E.M. 1983: Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat Artery 12(2): 81-94
Moody, D.E.; Reddy, J.K. 1974: Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate Research Communications in Chemical Pathology and Pharmacology 9(3): 501-510
De Gennes, J.L.; Dairou, F.; Surbled-Delas, B. 1978: Demonstration of the role of cholelithiasis in the onset of acute pancreatitis occurring during clofibrate (or its analog) treatment of atherogenic hyperlipemia Annales de Medecine Interne 129(6-7): 435-439
Zeng, H.; Liu, P. 2014: Update on anaphylaxis-induced acute coronary syndrome Zhonghua Xin Xue Guan Bing Za Zhi 42(5): 441-443
Carnevalini, M.; Giorgi, M.; Waldman, S.; Caturla, N.ás.; Ovejero, R.; Falconi, E.; San Miguel, L.; Caroli, C.; Magariños, E.; Cohen Arazi, H.án. 2011: Contrast induced nephropathy in acute coronary syndrome Medicina 71(5): 441-448
Higashi, H.; Ehira, T.; Kobayashi, T.; Shimoji, K.; Hirayama, K. 1972: Treatment of acute bromvalerylurea (Brovalin) poisoning by peritoneal dialysis--analysis of bromvalerylurea in the dialysis solution Masui. Japanese Journal of Anesthesiology 21(1): 81-86